BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7869410)

  • 21. [Quantitative basis of a method for the recalcification of citrated blood in researching blood coagulation].
    Sukhanov VA; Koriakov IO
    Lab Delo; 1985; (12):722-4. PubMed ID: 2418267
    [No Abstract]   [Full Text] [Related]  

  • 22. Nasal toxicity of cocaine: a hypercoagulable effect?
    Patel R; Shah R; Baredes S; Spillert CR; Lazaro EJ
    J Natl Med Assoc; 2000 Jan; 92(1):39-41. PubMed ID: 10800286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Signs of hypercoagulability in hyperlipemic hypertensives].
    Vucenik I; Martinić P; Dujmović M; Dubravcić M
    Bilt Hematol Transfuz; 1980; 8(1):71-81. PubMed ID: 7337684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives.
    Glazer NL; Smith NL; Heckbert SR; Doggen CJ; Lemaitre RN; Psaty BM
    Am J Hypertens; 2005 Jun; 18(6):759-66. PubMed ID: 15925732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered levels of erythrocyte calcium-binding proteins in essential hypertensives with genetic predisposition: correlation with ambulatory blood pressure.
    Hojo Y; Ebata H; Kawasaki K; Tsuruya Y; Ikeda U; Nishinaga M; Natsume T; Ishida H; Shimada K
    J Hypertens; 1994 Apr; 12(4):429-37. PubMed ID: 8064167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired glucose metabolism in hypertensive patients.
    Fragachan F; Perez-Acuña F; Monsalve P; Sanabria A
    Clin Physiol Biochem; 1990; 8(4):188-203. PubMed ID: 2078921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives.
    Jankowski V; Meyer AA; Schlattmann P; Gui Y; Zheng XL; Stamcou I; Radtke K; Tran TN; van der Giet M; Tölle M; Zidek W; Jankowski J
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1776-81. PubMed ID: 17569882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypercoagulable states.
    Rogers JS
    W V Med J; 1993 Feb; 89(2):61-3. PubMed ID: 8442350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma renin activity in patients with ischaemic heart disease.
    Urbánek J; Hofman O; Reisenauer R; Slabý A
    Nuklearmedizin; 1977 Apr; 16(2):68-70. PubMed ID: 876844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemorheological and fibrinolytic activity in hypertensive Nigerians.
    Aigbe A; Famodu AA
    Clin Hemorheol Microcirc; 1999; 21(3-4):415-20. PubMed ID: 10711779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy.
    Donahue SM; Brooks M; Otto CM
    J Vet Emerg Crit Care (San Antonio); 2011 Aug; 21(4):346-55. PubMed ID: 21827592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies of the association between angiotensinogen gene regulation and cytokines in essential hypertension].
    Wang AL; Yu YX; Xu Y; Liu P; Chen ZP; Zhang L; Wu JX; Sun GM; Chen S
    Yi Chuan Xue Bao; 2003 Oct; 30(10):978-82. PubMed ID: 14669517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a hypertensive factor in the blood of essential hypertensives.
    Zidek W; Sachinidis A; Schmidt W; Storkebaum W; Losse H; Vetter H
    Klin Wochenschr; 1985; 63 Suppl 3():113-6. PubMed ID: 3999627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The modified recalcification time (MRT) test assesses suppressive effect of general anesthesia (GA) on monocyte function.
    Ponnudurai R; Ramasubramaniam H; Spillert CR; Bonthu S; Lazaro EJ
    Inflamm Res; 1995 Aug; 44 Suppl 2():S193. PubMed ID: 8548393
    [No Abstract]   [Full Text] [Related]  

  • 37. Outward Na+-K+-Cl- cotransport function in erythrocytes from essential hypertensives.
    de la Sierra A; Coca A; Aguilera MT; Urbano-Márquez A
    J Hum Hypertens; 1989 Feb; 3(1):1-8. PubMed ID: 2724269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shortened endotoxin-activated clotting times in patients with carcinoma.
    Spillert CR; Lazaro EJ
    Am Surg; 1987 Mar; 53(3):164-6. PubMed ID: 3548512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borderline hypertension. Circulatory, sympatho-adrenal and psychological reactions to stress.
    Eliasson K
    Acta Med Scand Suppl; 1985; 692():1-90. PubMed ID: 3883705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of salt taste threshold of hypertensives, their normotensive relatives and non-relatives.
    Olayemi SO; Mabadeje AF
    Niger Postgrad Med J; 2003 Jun; 10(2):96-8. PubMed ID: 14567044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.